Tag: clinical trials

Monitoring and Quality Management in DCT and Hybrid Trial Designs

Posted on By digi

Monitoring and Quality Management in DCT and Hybrid Trial Designs In the evolving landscape of clinical research, decentralized clinical trials (DCT) and hybrid trial designs have emerged as essential methodologies, especially in the context of prostate cancer clinical trials. The complexity of these frameworks necessitates robust monitoring and quality management strategies to ensure data integrity…

Read More “Monitoring and Quality Management in DCT and Hybrid Trial Designs” »

Oversight of DCT/Hybrid Sites

Ensuring GCP Compliance Across Traditional and Virtual Site Footprints

Posted on By digi

Ensuring GCP Compliance Across Traditional and Virtual Site Footprints Ensuring GCP Compliance Across Traditional and Virtual Site Footprints In the evolving landscape of clinical research, ensuring compliance with Good Clinical Practice (GCP) remains a primary concern for clinical operations, regulatory affairs, and medical affairs professionals. This comprehensive guide outlines the steps necessary to ensure GCP…

Read More “Ensuring GCP Compliance Across Traditional and Virtual Site Footprints” »

Oversight of DCT/Hybrid Sites

What Regulators Look for in EDC, ePRO and Safety System Audit Trails

Posted on By digi

What Regulators Look for in EDC, ePRO and Safety System Audit Trails What Regulators Look for in EDC, ePRO and Safety System Audit Trails In the landscape of clinical research, maintaining data integrity and ensuring compliance with regulatory standards have become paramount. Electronic Data Capture (EDC), Electronic Patient Reported Outcomes (ePRO), and safety systems are…

Read More “What Regulators Look for in EDC, ePRO and Safety System Audit Trails” »

Audit Trails & Access Controls

Audit Trail Review Strategies for Risk-Based Monitoring and QA

Posted on By digi

Audit Trail Review Strategies for Risk-Based Monitoring and QA Audit Trail Review Strategies for Risk-Based Monitoring and QA In the progressively intricate landscape of clinical research, adhering to regulatory expectations surrounding audit trails is crucial for ensuring compliance and data integrity. This comprehensive tutorial guides clinical operations, regulatory affairs, and medical affairs professionals through the…

Read More “Audit Trail Review Strategies for Risk-Based Monitoring and QA” »

Audit Trails & Access Controls

Mapping Clinical Questions to Estimands Under ICH E9(R1)

Posted on By digi

Mapping Clinical Questions to Estimands Under ICH E9(R1) Mapping Clinical Questions to Estimands Under ICH E9(R1) The importance of accurately defining and interpreting estimands in clinical trial design is increasingly recognized in regulatory guidelines, particularly after the introduction of the ICH E9(R1) document, which focuses on the need to understand the clinical question being addressed….

Read More “Mapping Clinical Questions to Estimands Under ICH E9(R1)” »

Estimands & Handling Intercurrent Events

Oversight Models for Decentralized and Hybrid Clinical Trial Sites

Posted on By digi

Oversight Models for Decentralized and Hybrid Clinical Trial Sites Oversight Models for Decentralized and Hybrid Clinical Trial Sites The evolution of clinical trials has risen significantly due to technological advancements and changing patient expectations, leading to the emergence of decentralized and hybrid clinical trial models. These models offer potential benefits such as improved patient access…

Read More “Oversight Models for Decentralized and Hybrid Clinical Trial Sites” »

Oversight of DCT/Hybrid Sites

Risk-Based Oversight of Home Health, Local Labs and Community Providers

Posted on By digi

Risk-Based Oversight of Home Health, Local Labs and Community Providers Risk-Based Oversight of Home Health, Local Labs and Community Providers In the ever-evolving landscape of clinical trials, particularly with the rise of decentralized clinical trials (DCT) and hybrid models, the need for effective risk-based monitoring (RBM) has never been more critical. This article provides a…

Read More “Risk-Based Oversight of Home Health, Local Labs and Community Providers” »

Oversight of DCT/Hybrid Sites

Audit Trails and Access Controls: Core Defenses for Clinical Data Integrity

Posted on By digi

Audit Trails and Access Controls: Core Defenses for Clinical Data Integrity Audit Trails and Access Controls: Core Defenses for Clinical Data Integrity In the realm of clinical trials, ensuring the integrity of data is paramount. Regulatory bodies like the FDA, EMA, and MHRA mandate stringent guidelines for data management that encompass audit trails and access…

Read More “Audit Trails and Access Controls: Core Defenses for Clinical Data Integrity” »

Audit Trails & Access Controls

Configuring System Roles and Permissions to Support Least-Privilege Access

Posted on By digi

Configuring System Roles and Permissions to Support Least-Privilege Access In today’s clinical research landscape, especially for prostate cancer clinical trials, ensuring data integrity and security is paramount. The implementation of robust system roles and permissions aligned with the principle of least-privilege access plays a critical role in protecting sensitive data and meeting regulatory compliance standards….

Read More “Configuring System Roles and Permissions to Support Least-Privilege Access” »

Audit Trails & Access Controls

Estimands in Clinical Trials: From Concept to Implementation

Posted on By digi

Estimands in Clinical Trials: From Concept to Implementation Estimands in Clinical Trials: From Concept to Implementation The evolving landscape of clinical trials has introduced the concept of estimands, offering a structured framework for defining treatment effects while accounting for practical variables inherent in real-world situations. This tutorial provides an in-depth exploration of estimands, their significance,…

Read More “Estimands in Clinical Trials: From Concept to Implementation” »

Estimands & Handling Intercurrent Events